Dr. Frederic F. Rahbari Oskoui, MD

Dr. Rahbari Oskoui practices at Emory University Hospital in Atlanta, Georgia, part of Emory University.

Dr. Rahbari Oskoui's NPI, 1295766335, was assigned on July 6, 2006. Dr. Rahbari Oskoui holds Georgia license 053568.

Dr. Rahbari Oskoui's primary practice is Emory University Hospital, at 1364 Clifton Road, NE, Atlanta, GA 30322 in De Kalb County. The practice phone is (404) 686-8500.

Dr. Rahbari Oskoui's primary practice is Emory University Hospital in Atlanta, Georgia, part of Emory University. Dr. Rahbari Oskoui is also affiliated with Emory University Hospital Midtown. The medical group on file is Emory Clinic. Dmand AI also links Dr. Rahbari Oskoui to 1 more hospital, 1 dialysis center, 1 ambulatory surgery center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rahbari Oskoui practices, 5 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Rahbari Oskoui's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Rahbari Oskoui is licensed in Georgia.

CMS data shows 590 Medicare services from Dr. Rahbari Oskoui across 10 procedure codes in 2024, for 182 Medicare patients. Medicare paid $59,229 for them.

CMS counts 182 Medicare patients who saw Dr. Rahbari Oskoui in 2024. The largest group is 65 to 74, with 74 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 24% are also on Medicaid. Their average risk score is 3.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rahbari Oskoui's median patient age at 67, with 54% women.

In 2024, Dr. Rahbari Oskoui wrote 815 Medicare Part D claims for 109 patients. 75% of them were for generic drugs. CMS names the drug for 602 of them, across 21 drugs with 11 or more claims each, at $144,549 in total drug cost. In 2023, CMS named 429 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Rahbari Oskoui for performance year 2024, reported through an alternative payment model (APM). Dr. Rahbari Oskoui accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rahbari Oskoui as offering telehealth.

Dmand AI links 7 papers to Dr. Rahbari Oskoui, published from 2011 to 2020. 2017 was the busiest year, with 2. Dr. Rahbari Oskoui's most frequent co-authors are Vicente E. Torres, MD, Ronald D. Perrone, MD and Theodore Irving Steinman, MD.

Dmand AI links Dr. Rahbari Oskoui to 2 clinical trials. Conditions studied include Polycystic Kidney, Autosomal Dominant and Polycystic Kidney Diseases.

CMS Open Payments shows 92 general payments to Dr. Rahbari Oskoui from 10 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 53% of the total. Otsuka Pharmaceutical Development & Commercialization, Inc. paid the most, $78,019. It also lists 1 research payment totaling $125 in 2018.